West Pharmaceutical director receives 44-unit award
Her phantom stock-unit award is scheduled to settle through delivery of shares upon her termination as a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Janet Brutschea Haugen, a director of West Pharmaceutical Services Inc., received an award of 44 phantom stock units on September 30, 2026. Her reported post-award balance was 350.87 phantom stock units, which are to be settled by delivery of shares upon her termination as a director. A separate entry reports 2,114 shares of common stock held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Unit F2 | 44 | $370.76 | $16K |
| holding | Common Stock F1 | -- | -- | -- |
Footnotes (2)
- F1. Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2. Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Key Figures
Key Terms
Phantom stock units financial
restricted stock units financial
dividend equivalents financial
Deferred Compensation Plan for Outside Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many WST phantom stock units did Janet Brutschea Haugen receive?
When do Janet Brutschea Haugen’s WST restricted stock units vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.